Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 6 II, 2000, Pages 1146-1152

  Nakamura, Yutaka ^a   Christodoulopoulos, Pota ^a   Cameron, Lisa ^a   Wright, Erin ^b   Lavigne, Francois ^c   Toda, Masao ^a   Muro, Shigeo ^a   Ray, Anuradha ^d   Eidelman, David H ^a   Minshall, Eleanor ^a   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergen; Allergic rhinitis; GATA 3; IL 5; Transcription factors

Indexed keywords

TRANSCRIPTION FACTOR GATA 3;

ALLERGIC RHINITIS; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROVOCATION TEST; TISSUE PREPARATION;

EID: 0033916858     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.107045     Document Type: Article

References (27)

1. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani AM, Schwartz LB, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992;146:170-6.
2. Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, et al. T cells are the principle source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Res Cell Mol Biol 1993;9:356-60.
3. Ying S, Durham SR, Jacobson MR, Rak S, Masuyama K, Lowhagen O, et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:200-6.
4. Ghaffar O, Laberge S, Jacobson MR, Lowhagen O, Rak S, Durham SR, et al. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. Am J Respir Cell Mol Biol 1997;17:17-24.
5. Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol; 1992;90:160-8.
6. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
7. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992;148:1086-92.
8. Stranick KS, Payvandi F, Zambas DN, Umland SP, Egan RW, Billah MM. Transcription of the murine interleukin 5 gene is regulated by multiple promoter elements. J Biol Chem 1995;270:20575-82.
9. Siegel MD, Zhang DH, Ray P, Ray A. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLEO elements. J Biol Chem 1995;270:24548-55.
10. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997;272:21597-603.
11. Zheng WP, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-96.
12. Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, Zhang DH, et al. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 1999;103:215-22.
13. Cameron L, Christodoulopoulos P, Lavigne F, Nakamura Y, Eidelman D, McEuen A, et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 2000;164:1538-45.
14. Okamoto Y, Shirotori K, Kudo K, Ishikawa K, Ito E, Togawa K, et al. Cytokine expression after the topical administration of substance P to human nasal mucosa. The role of substance P in nasal allergy. J Immunol 1993;151:4391-8.
15. Christodoulopoulos P, Wright E, Frenkiel S, Luster A, Hamid Q. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol 1999;103:1036-44.
16. Hamid Q, Wharton J, Terenghi G, Hassall C, Aimi J, Taylor K, et al. Localization of atrial natriuretic peptide mRNA and immunoreactivity in rat heart and human atrial appendage. Proc Natl Acad Sci U S A 1987;84:6760-4.
17. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, et al. Expression of mRNA for interleukin-5 in mucosal biopsies from asthma. JClin Invest 1991;87:1541-6.
18. Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:192-9.
19. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31.
20. Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155:845-51.
21. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
22. Masuyama K, Till SJ, Jacobson MR, Kamil A, Cameron L, Juliusson S, et al. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids. J Allergy Clin Immunol 1998;102:610-7.
23. Pawankar RU, Okuda M, Hasegawa S, Suzuki, Yssel H, Okubo K, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059-67.
24. Kuo CT, Leiden JM. Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 1999;17:149-87.
25. Ferber IA, Lee HJ, Zonin F, Heath V, Mui A, Arai N, et al. GATA-3 significantly downregulates IFN-gamma production from developing Thl cells in addition to inducing IL-4 and IL-5 levels. Clin Immunol 1999;91:134-44.
26. Blumenthal SG, Aichele G, Wirth T, Czernilofsky AP, Nordheim A, Dittmer J. Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets 1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Taxi. J Biol Chem 1999;274:12910-6.
27. Ghaffar O, Christodoulopoulos P, Lamkhioued B, Wright E, Ihaku D, Nakamura Y, et al. In vivo expression of signal transducer and activator of transcription factor (Stat 6) in nasal mucosa from atopic allergic rhinitis. Effect of topical corticosteroids. Clin Exp Allergy 2000;30:86-93.